Tag: eporetherapy

Filter by Topic
Filter by Topic
Mirai Medical treats the first skin cancer patient in Australia with ePORE® therapy
Read More
First live surgery demonstration of Mirai Medical’s ePORE® therapy for the treatment of gastrointestinal cancers
Read More
First patient with oesophageal cancer is treated in Germany using ePORE® therapy with EndoVE®
Read More

Contact Us

By clicking send, you confirm you have read and agreed to Mirai Medical's Privacy Policy.
Twitter Linkedin-in Youtube
ePORE Therapy White Logo
Address:
Mirai Medical
Unit 5, Howley Court
Oranmore
Galway
Ireland
Email:
info@mirai-medical.com
Mirai Medical logo white
© Copyright 2025 MIRAI MEDICAL. All Rights Reserved.
Privacy & Cookies
ePORE® therapy, EndoVE® and CUTIS are approved for commercialisation in the European Union, United Kingdom and Australia. ePORE® therapy, EndoVE® and CUTIS are not cleared by FDA for commercialisation in the USA.
WEEE Ireland Certificate of Registration MIR 100
PRL Registration Number: IE 02581 WB
Website by Proactive Design & Marketing